Credit Suisse’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-401,484
Closed -$356K 3938
2022
Q4
$356K Sell
401,484
-624,990
-61% -$829K ﹤0.01% 2948
2022
Q3
$1.61M Buy
1,026,474
+741,671
+260% +$1.68M ﹤0.01% 1988
2022
Q2
$573K Sell
284,803
-219
-0.1% -$379 ﹤0.01% 2757
2022
Q1
$664K Buy
285,022
+14,269
+5% +$44.5K ﹤0.01% 2813
2021
Q4
$1.26M Sell
270,753
-10,561
-4% -$65.6K ﹤0.01% 3140
2021
Q3
$2.15M Sell
281,314
-101,689
-27% -$862K ﹤0.01% 2757
2021
Q2
$3.71M Buy
383,003
+190,582
+99% +$1.52M ﹤0.01% 2343
2021
Q1
$1.59M Sell
192,421
-261,431
-58% -$2.76M ﹤0.01% 2984
2020
Q4
$3.1M Buy
453,852
+50,914
+13% +$409K ﹤0.01% 2488
2020
Q3
$4.49M Sell
402,938
-20,029
-5% -$183K ﹤0.01% 1862
2020
Q2
$2.66M Buy
+422,967
New +$1.62M ﹤0.01% 2156
2020
Q1
Sell
-135,979
Closed -$459K 4323
2019
Q4
$459K Buy
135,979
+60,781
+81% +$145K ﹤0.01% 3616
2019
Q3
$161K Buy
75,198
+3,668
+5% +$8.55K ﹤0.01% 3911
2019
Q2
$191K Sell
71,530
-5,348
-7% -$19.2K ﹤0.01% 3855
2019
Q1
$364K Buy
76,878
+9,959
+15% +$26.1K ﹤0.01% 3512
2018
Q4
$160K Buy
66,919
+3,794
+6% +$12.4K ﹤0.01% 3707
2018
Q3
$278K Sell
63,125
-10,404
-14% -$57.7K ﹤0.01% 3555
2018
Q2
$529K Buy
+73,529
New +$500K ﹤0.01% 3393
2017
Q2
Sell
-12,092
Closed -$48K 4008
2017
Q1
$48K Sell
12,092
-5,418
-31% -$27.2K ﹤0.01% 3747
2016
Q4
$85K Buy
17,510
+3,091
+21% +$18.6K ﹤0.01% 3973
2016
Q3
$112K Sell
14,419
-2,246
-13% -$15.1K ﹤0.01% 3913
2016
Q2
$94K Buy
16,665
+3,271
+24% +$20.9K ﹤0.01% 4071
2016
Q1
$72K Sell
13,394
-159
-1% -$924 ﹤0.01% 3864
2015
Q4
$118K Sell
13,553
-22
-0.2% -$186 ﹤0.01% 4053
2015
Q3
$114K Buy
13,575
+735
+6% +$11.7K ﹤0.01% 4083
2015
Q2
$226K Sell
12,840
-46,692
-78% -$600K ﹤0.01% 4162
2015
Q1
$689K Buy
+59,532
New +$689K ﹤0.01% 3299
2014
Q2
Sell
-18,800
Closed -$241K 4847
2014
Q1
$241K Buy
+18,800
New +$208K ﹤0.01% 4242

Other funds holding SRNE